Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Prothrombin
Most Correlated Studies
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- Prothrombin prevents fatal T cell-dependent anemia during chronic virus infection of mice.
- Antibody profiles comprising anti phosphatidylserine/prothrombin differently affect thrombin generat…
- PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Ence…
- Decrease of prothrombin level during thrombolysis in acute myocardium infarction.
- Rapid and ordered cleavage of prothrombin by Hopsarin D in the absence of phospholipid membranes.
Most Relevant Clinical Trials
- Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Re…
- Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-a…
- Prothrombin Complex Concentrate for Anticoagulant Reversal
- Reversal of Dabigatran With Prothrombin Complex Concentrate
- A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Com…
